We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Exome Sequencing Identified Pathogenic Variants in Cerebral Palsy Patients

By LabMedica International staff writers
Posted on 18 Feb 2021
Print article
Image: Exome sequencing workflow: Double-stranded genomic DNA is fragmented by sonication. Linkers are then attached to the DNA fragments, which are then hybridized to a capture microarray designed to target only the exons (Photo courtesy of SarahKusala).
Image: Exome sequencing workflow: Double-stranded genomic DNA is fragmented by sonication. Linkers are then attached to the DNA fragments, which are then hybridized to a capture microarray designed to target only the exons (Photo courtesy of SarahKusala).
Cerebral palsy (CP) is a group of permanent movement disorders that appear in early childhood. Signs and symptoms vary among people and over time. Often, symptoms include poor coordination, stiff muscles, weak muscles, and tremors.

Cerebral palsy is caused by abnormal development or damage to the parts of the brain that control movement, balance, and posture. Most often, the problems occur during pregnancy; however, they may also occur during childbirth or shortly after birth. While CP has often been attributed to oxygen deprivation during birth, recent studies have suggested that birth asphyxia accounts for less than 10% of cerebral palsy cases and that genetic variants affect disease risk.

Medical Scientists at the Geisinger Medical Center (Danville, PA, USA) and their colleagues carried out a retrospective, cross-sectional cohort study of cerebral palsy. One cohort consisted of 1,345 individuals with cerebral palsy had a median age of 8.8 years old and underwent exome sequencing at GeneDx (Gaithersburg, MD, USA). The other cohort, meanwhile, included 181 individuals with cerebral palsy who were a median age of 41.9 years old and who were recruited from the DiscoverEHR project from Geisinger and the Regeneron Genetics Center. This second cohort underwent research-based exome sequencing.

The team reported that for the younger cohort exome sequencing led to a positive diagnostic result for 440 patients, or 32.7%. Trio testing, the test subject and both biological parents, was available for a subset of that cohort, which boosted diagnostic yield from 23.3% for the affected individuals only to 35.4% in trio testing. Meanwhile, exome sequencing led to a positive diagnostic result for 19 patients, or 10.5%, from the second, older cohort.

Additionally, the scientists identified genes that harbored alterations in two or more unrelated individuals with cerebral palsy, including CTNNB1, KIF1A, GNAO1, and TUBA1A. Mutations in CTNNB1, they noted, have previously been reported in individuals with cerebral palsy and an autosomal dominant neurodevelopmental disorder marked by intellectual disability, spasticity, microcephaly, and visual defects. Pathogenic and likely pathogenic variants were identified in 229 genes (29.5% of 1,526 patients); 86 genes were mutated in two or more patients (20.1% of 1526 patients) and 10 genes with mutations were independently identified in both cohorts (2.9% of 1526 patients).

Andrés Moreno De Luca, a Neuroradiologist and assistant professor and first author of the study, said, “Finding a genetic etiology has the potential to prompt changes in clinical management, provide an end to the diagnostic odyssey and important prognostic information for patients and families, inform recurrence risk for future children born to the same parents, and may have medicolegal implications in cases of alleged birth asphyxia.”

The authors concluded that among two cohorts of patients with cerebral palsy who underwent exome sequencing, the prevalence of pathogenic and likely pathogenic variants was 32.7% in a cohort that predominantly consisted of pediatric patients and 10.5% in a cohort that predominantly consisted of adult patients. The study was published on February 2, 2021 in the Journal of the American Medical Association.

Related Links:
Geisinger Medical Center
GeneDx


New
Gold Supplier
Liquid Handling Workstation
AdvanSure E3 SYSTEM
New
Methicillin-Resistant Staphylococcus Aureus RT PCR Test
VIASURE Methicillin-Resistant Staphylococcus Aureus Real Time PCR Detection Kit
New
Automated RNA Extraction & PCR Setup
Omnia LH 75 Pro
New
Laboratory Management Software
HERA

Print article

Channels

Pathology

view channel

Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections

CerTest Biotec (Zaragoza, Spain) has joined the fight against multidrug resistant strains (MDR) bacterial infections by developing real-time PCR assays for the fast detection of genes or punctual mutations that confer resistance to antibiotics from both Gram-positive and Gram-negative pathogens. Resistance to antibiotics... Read more

Industry

view channel
Illustration

Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.